INTERNAL MEDICINE AND GERIATRICS / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Diabetes mellitus (DM) is associated with increased mortality in hospitalized adults. However, data regarding the impact of DM on long-term mortality after discharge in very old patients are scarce. This prospective study assessed 3-year post-discharge mortality and its predictive factors in older patients, focusing on possible differences between patients with and without DM.

Material and methods:
Medical history, chronic medication use, clinical and laboratory characteristics, Charlson Comorbidity Index (CCI), 5-item Fried Frailty Score (FFS), Clinical Frailty Scale (CFS), Barthel Index (BI), and Katz Index were recorded on admission.

Results:
A total of 815 older adults (46.0% males) with a median age of 83.0 years (IQR: 77.0–88.0) were included in the study. The 3-year mortality rate was 54.9% in patients with DM (n = 368) and 60.2% in patients without DM (n = 447, p = 0.13 between groups). In multivariate logistic analysis, nursing home residency, higher CCI, higher CFS, higher FFS, lower BI, the total number of days of hospitalization in the past year, and hospital-acquired infections were independently associated with the 3-year mortality in both groups. In individuals with DM, lower body mass index (BMI) and elevated urine albumin-to-creatinine ratio (UACR) were identified as additional independent predictors of 3-year mortality.

Conclusions:
A high post-discharge mortality rate was observed in very old patients. DM was not identified as an independent factor of post-discharge mortality. Assessment of frailty and disability in very old patients is important for predicting long-term post-discharge mortality. Additionally, in patients with DM, evaluating BMI and UACR may aid in better prediction of 3-year mortality.
REFERENCES (50)
1.
Fadnes LT, Celis-Morales C. Life expectancy can increase by up to 10 years following sustained shifts towards healthier diets in the United Kingdom. Nat Food 2023; 4: 961-8.
 
2.
Singh S, Bajorek B. Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy. Pharm Pract (Granada) 2014; 12: 489.
 
3.
Khan SS, Singer BD, Vaughan DE. Molecular and physiological manifestations and measurement of aging in humans. Aging Cell 2017; 16: 624-33.
 
4.
Bellary S, Kyrou I. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol 2021; 17: 534-48.
 
5.
Dal Canto E, Ceriello A, Rydén L, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro- and microvascular complications. Eur J Prev Cardiol 2019; 26 (2 Suppl): 25-32.
 
6.
Huang ES. Management of diabetes mellitus in older people with comorbidities. BMJ 2016; 353: i2200.
 
7.
Bhatt PP, Sheth MS. Comparison of fatigue and functional status in elderly type 2 diabetes patients versus age and gender matched individuals. Aging Med (Milton) 2024; 7: 84-9.
 
8.
Forbes A. Reducing the burden of mortality in older people with diabetes: a review of current research. Front Endocrinol (Lausanne) 2020; 11: 133.
 
9.
Hazar A, Gundogus B. Assessment of inflammatory markers, disease severity and comorbidities in very elderly patients with acute respiratory diseases. Arch Med Sci 2025; 21: 451-62.
 
10.
Cybulski M, Krajewska-Kułak E, Sowa P, et al. Elderly peoples’ perception of young people – a preliminary study. Iran J Public Health 2013; 42: 1099-105.
 
11.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14: 61-5.
 
12.
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-9.
 
13.
Rockwood K, Theou O. Using the Clinical Frailty Scale in allocating scarce health care resources. Can Geriatr J 2020; 23: 210-5.
 
14.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-56.
 
15.
Huang YQ, Gou R, Diao YS, et al. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J Zhejiang Univ Sci B 2014; 15: 58-66.
 
16.
Beretta MV, Dantas Filho FF, Freiberg RE, Feldman JV, Nery C, Rodrigues TC. Sarcopenia and type 2 diabetes mellitus as predictors of 2-year mortality after hospital discharge in a cohort of hospitalized older adults. Diabetes Res Clin Pract 2020; 159: 107969.
 
17.
Kozioł M, Towpik I, Żurek M, et al. Predictors of rehospitalization and mortality in diabetes-related hospital admissions. J Clin Med 2021; 10: 5814.
 
18.
Argano C, Natoli G, Mularo S, et al. Impact of diabetes mellitus and its comorbidities on elderly patients hospitalized in internal medicine wards: data from the RePoSi registry. Healthcare (Basel) 2022; 10: 86.
 
19.
Corrao S, Nobili A, Natoli G, et al. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry. Acta Diabetol 2021; 58: 1225-36.
 
20.
Smerdely P. Mortality is not increased with diabetes in hospitalised very old adults: a multi-site review. BMC Geriatr 2020; 20: 522.
 
21.
Corrao S, Argano C, Natoli G, et al. Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia. Eur J Intern Med 2018; 54: 53-9.
 
22.
Molina S, Martinez-Urrea A, Malik K, et al. Medium and long-term prognosis in hospitalised older adults with multimorbidity: a prospective cohort study. BMJ Open 2023; 18: e0285923.
 
23.
Soh CH, Lim WK, Reijnierse EM, Maier AB. Clinical frailty scale score during geriatric rehabilitation predicts short-term mortality: RESORT cohort study. Ann Phys Rehabil Med 2023; 66: 101645.
 
24.
Church S, Rogers E, Rockwood K, Theou O. A scoping review of the Clinical Frailty Scale. BMC Geriatr 2020; 20: 393.
 
25.
Conde-Martel A, Hemmersbach-Miller M, Marchena-Gomez J, Saavedra-Santana P, Betancor-Leon P. Five-year survival and prognostic factors in a cohort of hospitalized nonagenarians. Eur J Intern Med 2012; 23: 513-8.
 
26.
Tal S. Mortality in the oldest-old adults after discharge from acute geriatric ward. Gerontol Geriatr Med 2023; 9: 23337214231156300.
 
27.
Elias R, Hartshorn K, Rahma O, Lin N, Snyder-Cappione JE. Aging, immune senescence, and immunotherapy: a comprehensive review. Semin Oncol 2018; 45: 187-200.
 
28.
Tannou T, Koeberle S, Manckoundia P, Aubry R. Multifactorial immunodeficiency in frail elderly patients: contributing factors and management. Med Mal Infect 2019; 49: 167-72.
 
29.
Holt RIG, Cockram CS, Ma RCW. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabet Med 2024; 67: 1168-80.
 
30.
Cristina ML, Spagnolo AM, Giribone L, Demartini A, Sartini M. Epidemiology and prevention of healthcare-associated infections in geriatric patients: a narrative review. Int J Environ Res Public Health 2021; 18: 5333.
 
31.
Jump RL, Crnich CJ, Mody L, Bradley SF, Nicolle LE, Yoshikawa TT. Infectious diseases in older adults of long-term care facilities: update on approach to diagnosis and management. J Am Geriatr Soc 2018; 66: 789-803.
 
32.
Admi H, Shadmi E, Baruch H, Zisberg A. From research to reality: minimizing the effects of hospitalization on older adults. Rambam Maimonides Med J 2015; 6: e0017.
 
33.
Mudge AM, McRae P, Hubbard RE, Peel NM. Hospital-associated complications of older people: a proposed multicomponent outcome for acute care. J Am Geriatr Soc 2019; 67: 352-6.
 
34.
Boucaud-Maitre D, Letenneur L, Dramé M. Comparison of mortality and hospitalizations of older adults living in residential care facilities versus nursing homes or the community: a systematic review. BMJ Open 2023; 18: e0286527.
 
35.
Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-96.
 
36.
Kim YG, Han KD, Roh SY, et al. Being underweight is associated with increased risk of sudden cardiac death in people with diabetes mellitus. J Clin Med 2023; 12: 1045.
 
37.
Hong JS, Kang HC. Body mass index and all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus in South Korea: a retrospective cohort study. BMJ Open 2022; 12: e048784.
 
38.
Werner C, Sturm M, Heldmann P, Fleiner T, Bauer JM, Hauer K. Predictors of 2-year post-discharge mortality in hospitalized older patients. J Clin Med 2024; 13: 1352.
 
39.
Dramé M, Godaert L. The obesity paradox and mortality in older adults: a systematic review. Nutrients 2023; 15: 1780.
 
40.
Lewandowicz A, Sławiński P, Kądalska E, Targowski T. Some clarifications of terminology may facilitate sarcopenia assessment. Arch Med Sci 2020; 16: 225-32.
 
41.
He Q, Xia W. Analysis of the current status of computed tomography diagnosis of sarcopenia. Arch Med Sci 2025; 21: 374-82.
 
42.
Yu Z, Liang K, Chen X, Tang H, Chen X. Association of the triglyceride glucose index with computed tomography-based low muscle mass. Arch Med Sci 2025 May 5. doi:10.5114/aoms/203760.
 
43.
Chan HCN, Fei X, Leung ELY, Langston K, Marshall S, van der Meij BS. Post-discharge consequences of protein-energy malnutrition, sarcopenia, and frailty in older adults admitted to rehabilitation: a systematic review. Clin Nutr ESPEN 2023; 54: 382-97.
 
44.
Constans T, Bacq Y, Bréchot JF, Guilmot JL, Choutet P, Lamisse F. Protein-energy malnutrition in elderly medical patients. J Am Geriatr Soc 1992; 40: 263-8.
 
45.
Wang J, Chen Z, Chen L. Nutritional burden from the global burden of disease. Arch Med Sci 2024; 20: 1077-88.
 
46.
Barzilay JI, Buzkova P, Shlipak MG, Bansal N, Garimella P, Mukamal KJ. Hospitalization rates in older adults with albuminuria: the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci 2020; 75: 2426-33.
 
47.
Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 2002; 61: 2165-75.
 
48.
de Boer IH, Katz R, Cao JJ, et al. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care 2009; 32: 1833-8.
 
49.
Bakker WM, Gansevoort RT. Sodium-glucose cotransporter 2 inhibitors in older patients with CKD. J Am Soc Nephrol 2024; 35: 1446-9.
 
50.
Onoviran OF, Li D, Toombs Smith S, Raji MA. Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus. Ther Adv Chronic Dis 2019; 10: 2040622319862691.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top